Ionis Pharmaceuticals (NASDAQ:IONS) Upgraded to Hold at StockNews.com
StockNews.com upgraded shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) from a sell rating to a hold rating in a research report released on Saturday morning. Several other equities research analysts also recently weighed in on IONS. William Blair reissued an outperform rating on shares of Ionis Pharmaceuticals in a report on Monday, November 13th. […]
More Stories
Federal Judge Appears Skeptical of Bid to Block DOGE’s Access to Data
By Stacy Robinson A federal judge in Washington seemed reluctant on Feb. 17 to issue a temporary restraining order (TRO)...
11 Dead in Kentucky Flooding as Another Winter Storm Approaches
By Chase Smith The death toll from severe flooding in Kentucky has risen to 11 as emergency responders continue search-and-rescue...
Nearly 1 in 3 Americans Have More Emergency Savings Than a Year Ago: Bankrate Survey
By Naveen Athrappully A sizable number of Americans have seen their emergency savings rise in 2025 compared with last year,...
How a US Iron Dome Could Reshape Global Nuclear Relations
By Ryan Morgan The U.S. Missile Defense Agency is already searching for cutting-edge missile defense technologies after President Donald Trump...
Headache Types and Ancient Methods for Quick Relief
By Naiwen Hu Some people experience headaches due to high work pressure or emotional stress. Traditional Chinese medicine (TCM) has...
Sovereignty and territorial integrity of Ukraine paramount, Security Council hears
A senior UN political affairs official on Monday reaffirmed that any peace deal in Ukraine must respect the country’s sovereignty,...